Clinical Trial Search

Primary: Progression-free for at Least 6 Months Without Non-protocol Therapy From Study Entry — 20 percentage of participants

Primary: Urinary Hippuric Acid — 16.4; 0; 10.5 mmol/24 hours

Primary: The Proportion of Patients Meeting the American College of Rheumatology 20% (ACR20) Response Criteria at Week 12 — 67.0; 61.1 Percentage of Patients

Primary: Scar Pain — 1.265; 1.181; 1.048; 1.084 units on a scale — p=0.0492

Primary: Number of HAE Attacks — 2.74; 4.36; 7.18 attacks

Primary: Change in HbA1c (Glycosylated Haemoglobin) — -1.48; -1.46 Percentage of glycosylated haemoglobin — p=<0.0001

Primary: The Number of Polyoma BK Viremia Patients — 5 Participants

Primary: Change From Baseline in Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) Total Score at Week 24 — 1.2; 0.5; -0.4 Score on scale — p=0.279

Primary: Composite Cognitive Function in Z-scores (i.e. Which Converts Raw Data to Standard Deviation (SD) Units: [Score-mean]/SD]). This Composite is Formed by Averaging the…

Primary: Average Contact Force Exerted on the Heel — 60.25; 39.74; 5.57; 29.34 mmHg — p=<0.00005

Primary: Change in Depressive Symptoms — 13.6; 13.4; 14.8; 15.0 units on a scale — p=0.07

Primary: Number of Participants With One or More Clinically Significant Event(s) — 4; 0; 2; 4 Participants

Primary: Auditory Arousal Threshold (AAT) at T-max — 85.2; 78.0; 103.2; 84.7 Decibels (dB)

Primary: Change From Baseline to Peak in Cerebrospinal Fluid (CSF) S100 Beta Within 48 Hours Following Descending Thoracic Aorta/Thoracoabdominal Aortic Aneurysm (DTA/TAAA)…

Primary: Overall Response Rate (ORR) — 27; 39; 23; 4 Participants